Veradermics Inc MANE:NYSE
RT Quote | Last NASDAQ LS, VOL From CTA | USD
After Hours: Last | 4:00 PM EDT96.74UNCH (UNCH)
Volume
16,068
Close
96.74
-1.44 (-1.47%)
-1.44 (-1.47%)Volume
563,024
52 week range
32.00 - 117.71
- Open97.56
- Day High97.98
- Day Low95.00
- Prev Close98.18
- 52 Week High117.71
- 52 Week High Date05/06/26
- 52 Week Low32.00
- 52 Week Low Date02/04/26
Latest On Veradermics Inc
Key Stats
- Market Cap4.042B
- Shares Out41.78M
- 10 Day Average Volume0.49M
- Dividend-
- Dividend Yield-
- Beta-
KEY STATS
- Open97.56
- Day High97.98
- Day Low95.00
- Prev Close98.18
- 52 Week High117.71
- 52 Week High Date05/06/26
- 52 Week Low32.00
- 52 Week Low Date02/04/26
- Market Cap4.042B
- Shares Out41.78M
- 10 Day Average Volume0.49M
- Dividend-
- Dividend Yield-
- Beta-
RATIOS/PROFITABILITY
- EPS (TTM)16.09
- P/E (TTM)6.01
- Fwd P/E (NTM)-
- EBITDA (TTM)-89.294M
- ROE (TTM)-
- Revenue (TTM)-
- Gross Margin (TTM)-
- Net Margin (TTM)-
- Debt To Equity (MRQ)-
EVENTS
- Earnings Date-
- Ex Div Date-
- Div Amount-
- Split Date-
- Split Factor-
Content From Our Affiliates
Related Video
watch now
Profile
MOREVeradermics, Incorporated is a late clinical-stage biopharmaceutical company. The Company is focused on developing innovative therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. Its initial focus is developing better treatments for pattern hair loss (PHL). The Company is developing VDPHL01 as an oral, non-hormonal treatment for men and women with PHL to reduce the barriers to wide adoption of chronic hair loss...
Reid Waldman M.D.
Chief Executive Officer, Co-Founder, Director
Timothy Durso M.D.
President, Co-Founder
Dominic Carrano CPA
Chief Financial Officer
Michael Greco J.D.
General Counsel
Address
470 James Street
New Haven, CT
06513
United States